⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PCVX News
Vaxcyte, Inc. Common Stock
Form 8-K
sec.gov
PCVX
Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data
globenewswire.com
PCVX
Vaxcyte to Participate in Upcoming Investor Conferences
globenewswire.com
PCVX
Form 8-K
sec.gov
PCVX
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
PCVX
Form 8-K
sec.gov
PCVX
Vaxcyte to Participate in Upcoming Investor Conferences
globenewswire.com
PCVX
Form 8-K
sec.gov
PCVX
Form 8-K
sec.gov
PCVX
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
globenewswire.com
PCVX